Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) COO Daryl Gaugler sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $38.74, for a total transaction of $38,740.00. Following the transaction, the chief operating officer now owns 23,591 shares in the […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) CFO Charles A. Reinhart III sold 1,236 shares of the firm’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $38.99, for a total transaction of $48,191.64. Following the completion of the sale, the chief financial officer now owns 34,997 […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) CEO David M. Stack sold 5,058 shares of the company’s stock in a transaction that occurred on Tuesday, June 6th. The shares were sold at an average price of $38.99, for a total value of $197,211.42. Following the completion of the transaction, the chief executive officer now directly […]
Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) have been given a consensus rating of “Moderate Buy” by the thirteen research firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year […]
Dimensional Fund Advisors LP grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) by 8.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 947,369 shares of the company’s stock after acquiring an additional 70,141 shares during the period. Dimensional Fund Advisors LP’s holdings in Pacira BioSciences were worth […]